Interlaboratory variation in PD-L1 positivity in non-small cell lung cancer patients: a comparison between histological and cytological material

被引：0
|
作者：
Koomen, B. [1 ]
Voorham, R. [2 ]
Kuijpers, C. [1 ]
Deckers, I. [2 ]
Willems, S. [1 ]
机构：
[1] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands
[2] PALGA Fdn Nationwide Network & Registry Histo & C, Houten, Netherlands
来源：
VIRCHOWS ARCHIV | 2019年 / 475卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
OFP-10-004
引用
收藏
页码：S39 / S40
页数：2
相关论文
共 50 条
  • [21] PD-L1 Expression in Histological and Cytological Specimens and Outcomes Following Immunotherapy in Non-Small-Cell Lung Cancer
    Jackson, J.
    Valentine, E.
    Toy, E.
    Dorey, N.
    Powari, M.
    JOURNAL OF PATHOLOGY, 2019, 248 : S11 - S11
  • [22] Correlation of PD-L1 Expression with Histological Patterns and Treatment Response in Non-Small Cell Lung Cancer
    Beshai, Boulos
    Xu, Bo
    LABORATORY INVESTIGATION, 2018, 98 : 724 - 724
  • [23] Significance of PD-L1 expression in the cytological samples of non-small cell lung cancer patients treated with immune checkpoint inhibitors
    Naofumi Hara
    Eiki Ichihara
    Daijiro Harada
    Koji Inoue
    Keiichi Fujiwara
    Shinobu Hosokawa
    Daizo Kishino
    Kawai Haruyuki
    Nobuaki Ochi
    Naohiro Oda
    Katsuyuki Hotta
    Yoshinobu Maeda
    Katsuyuki Kiura
    Journal of Cancer Research and Clinical Oncology, 2021, 147 : 3749 - 3755
  • [24] PD-L1 Expression in Cytological and Histological Lung Cancer Specimens
    Hara, N.
    Tang, X.
    Islam, H.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2022, 158 (SUPP 1) : S150 - S150
  • [25] Significance of PD-L1 expression in the cytological samples of non-small cell lung cancer patients treated with immune checkpoint inhibitors
    Hara, Naofumi
    Ichihara, Eiki
    Harada, Daijiro
    Inoue, Koji
    Fujiwara, Keiichi
    Hosokawa, Shinobu
    Kishino, Daizo
    Haruyuki, Kawai
    Ochi, Nobuaki
    Oda, Naohiro
    Hotta, Katsuyuki
    Maeda, Yoshinobu
    Kiura, Katsuyuki
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (12) : 3749 - 3755
  • [26] Comparison of PD-L1 expression between paired cytologic and histologic specimens from non-small cell lung cancer patients
    C. Kuempers
    L. I. S. van der Linde
    M. Reischl
    W. Vogel
    F. Stellmacher
    M. Reck
    D. Heigener
    K. F. Rabe
    J. Kirfel
    S. Perner
    L. Welker
    Virchows Archiv, 2020, 476 : 261 - 271
  • [27] PD-L1 expression in resected non-small cell lung cancer: variation between primary tumour and nodal metastases
    Haragan, A.
    Gosney, J.
    Field, J. K.
    Davies, M.
    Escriu, C.
    Gruver, A.
    LUNG CANCER, 2019, 127 : S25 - S25
  • [28] Comparison of PD-L1 expression between paired cytologic and histologic specimens from non-small cell lung cancer patients
    Kuempers, C.
    van der Linde, L. I. S.
    Reischl, M.
    Vogel, W.
    Stellmacher, F.
    Reck, M.
    Heigener, D.
    Rabe, K. F.
    Kirfel, J.
    Perner, S.
    Welker, L.
    VIRCHOWS ARCHIV, 2020, 476 (02) : 261 - 271
  • [29] Biomarker role of thyroid irAE and PD-L1 positivity in predicting PD-1 blockade efficacy in patients with non-small cell lung cancer
    Kim, Hye In
    Kim, Won Gu
    Kim, Mijin
    Ko, Nak Gyeong
    Jin, Mihyeon
    Jung, Hyun Ae
    Sun, Jong-Mu
    Ahn, Jin Seok
    Ahn, Myung-Ju
    Choi, Yoon-La
    Jeon, Min Ji
    Kim, Tae Yong
    Kim, Won Bae
    Kim, Sang-We
    Lee, Dae Ho
    Jang, Se Jin
    Kim, Sun Wook
    Chung, Jae Hoon
    Kim, Tae Hyuk
    Lee, Se-Hoon
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (12)
  • [30] PD-1 and PD-L1 inhibitor toxicities in non-small cell lung cancer
    Shankar, Bairavi
    Naidoo, Jarushka
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S4034 - S4037
12345